(Q44233603)

1 December 2017

title

Antifungal susceptibility of South African oral yeast isolates from HIV/AIDS patients and healthy individuals (English)

1 reference

1 December 2017

0 references

1 reference

4

Pfaller MA

1 reference

1 December 2017

Blignaut E

1

1 reference

1 December 2017

Messer S

series ordinal

2

1 reference

1 December 2017

Hollis RJ

series ordinal

3

1 reference

1 December 2017

publication date

1 October 2002

1 reference

Diagnostic Microbiology and Infectious Disease

1 December 2017

published in

1 reference

1 December 2017

volume

44

1 reference

1 December 2017

issue

2

1 reference

1 December 2017

page(s)

169-174

1 reference

Oral manifestations of HIV infection in 600 South African patients.

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900440-6

7 January 2021

The prevalence and intra-oral distribution of Candida albicans in man

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900440-6

7 January 2021

Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900440-6

7 January 2021

Evaluation of prognosis and survival of the HIV-infected patient

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900440-6

7 January 2021

Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900440-6

7 January 2021

Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900440-6

7 January 2021

Activity of MK-0991 (L-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900440-6

7 January 2021

Epidemiology and control of fungal infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900440-6

7 January 2021

International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900440-6

7 January 2021

Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900440-6

7 January 2021

Oral candidiasis in HIV infection: predictive value and comparison of findings in injecting drug users and homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900440-6

7 January 2021

Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900440-6

7 January 2021

Resistance of Candida species to fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900440-6

7 January 2021

Prevalence of Candida species in AIDS patients and HIV-free subjects in Thailand.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900440-6

7 January 2021

Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900440-6

7 January 2021

10.1016/S0732-8893(02)00440-6

Identifiers

DOI

1 reference

1 December 2017

1 reference